# Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

> **NCT00197184** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 276 (actual)

## Conditions studied

- Hepatitis B
- Hepatitis A

## Interventions

- **BIOLOGICAL:** Twinrix™ Adult
- **BIOLOGICAL:** Twinrix™ Junior

## Key facts

- **NCT ID:** NCT00197184
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11-01
- **Primary completion:** 2004-03-10
- **Final completion:** 2004-03-10
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197184, "Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00197184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*